Total results2,176
Search criteria
All records
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| ANO2 | Q9NQ90 | Anoctamin-2 (Transmembrane protein 16B) | Predicted membrane proteinsTransporters | 8 | Clinical-translation mediationFusion and delivery mediation | 2 | 0.53 | |||
| ANO6 | Q4KMQ2 | Anoctamin-6 (Small-conductance calcium-activated nonselective cation channel) (SCAN channel) (Transmembrane protein 16F) | Disease related genesHuman disease related genesPotential drug targets | 10 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 2 | 0.53 | |||
| ANO9 | A1A5B4 | Anoctamin-9 (Transmembrane protein 16J) (Tumor protein p53-inducible protein 5) (p53-induced gene 5 protein) | Predicted membrane proteinsTransporters | 8 | Clinical-translation mediationFusion and delivery mediation | 2 | 0.53 | |||
| ANRA2 | Q9H9E1 | Ankyrin repeat family A protein 2 (RFXANK-like protein 2) | Predicted intracellular proteins | Other mediation | 2 | 0.53 | ||||
| ANXA3 | P12429 | Annexin A3 (35-alpha calcimedin) (Annexin III) (Annexin-3) (Inositol 1,2-cyclic phosphate 2-phosphohydrolase) (Lipocortin III) (Placental anticoagulant protein III) (PAP-III) | FDA approved drug targetsMetabolic proteinsPlasma proteins | Clinical-translation mediationFusion and delivery mediationImmune mediation | 2 | 0.53 | ||||
| AP2M1 | Q96CW1 | AP-2 complex subunit mu (AP-2 mu chain) (Adaptin-mu2) (Adaptor protein complex AP-2 subunit mu) (Adaptor-related protein complex 2 subunit mu) (Clathrin assembly protein complex 2 mu medium chain) (Clathrin coat assembly protein AP50) (Clathrin coat-associated protein AP50) (HA2 50 kDa subunit) (Plasma membrane adaptor AP-2 50 kDa protein) | Disease related genesEssential proteinsHuman disease related genes | EpilepsyIntellectual disability | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 2 | 0.53 | |||
| APJ | P35414 | Apelin receptor (Angiotensin receptor-like 1) (G-protein coupled receptor APJ) (G-protein coupled receptor HG11) | G-protein coupled receptorsPredicted membrane proteinsTransporters | 7 | Heart failure | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 2 | 0.53 | ||
| APLD1 | Q96LR9 | Apolipoprotein L domain-containing protein 1 (Vascular early response gene protein) | Predicted membrane proteins | 3 | Fusion and delivery mediation | 2 | 0.53 | |||
| APMAP | Q9HDC9 | Adipocyte plasma membrane-associated protein (Protein BSCv) | Plasma proteinsPredicted intracellular proteinsPredicted membrane proteins | 1 | Other mediation | 2 | 0.53 | |||
| AQP3 | Q92482 | Aquaporin-3 (AQP-3) (Aquaglyceroporin-3) | Blood group antigen proteinsMetabolic proteinsPlasma proteins | 6 | Fusion and delivery mediationMetabolism mediation | 2 | 0.53 |